OTCM
BFNH
Market cap298mUSD
Oct 07, Last price
8.89USD
1D
10.99%
1Q
396.93%
IPO
12,421.13%
Name
BioForce Nanosciences Holdings Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
BioForce Nanosciences Holdings, Inc. (BFNH) specializes in providing natural vitamins, minerals, and a variety of other nutritional supplements, along with powders and beverages, intended for individuals across all age demographics. The firm also operates in the private label market, collaborating with both distributors and production partners. Under its BioForce Eclipse brand, BFNH's dietary supplements reach consumers through a broad network of retailers, including general merchandise stores, sporting goods shops, grocery chains, and large mass merchandisers. Additionally, the company facilitates sales directly via its online presence and telemarketing campaigns. Its corporate base is situated in Virginia Beach, Virginia.
Key people
Kerry M. Frey
President, Chief Executive Officer, Director · since 2008
Eric R. Henderson
Executive Vice President, Chief Scientific Officer, Director · since 2008
Gregory D. Brown
Chief Financial Officer, Executive Vice President, Treasurer, Secretary · since 2007
Michael D. Dunham
Director · since 2007
Jean-Jacques Sunier
Director · since 2006
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||